|
1
|
Zemel R, Issachar A and Tur-Kaspa R: The
role of oncogenic viruses in the pathogenesis of hepatocellular
carcinoma. Clin Liver Dis. 15:261–279. vii–x. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cui XW, Chang JM and Dietrich CF: Should
hepatocellular carcinoma screening with ultrasound be recommended
in hepatocellular carcinoma high-incidence areas? Hepatology.
61:1091–1092. 2015. View Article : Google Scholar
|
|
3
|
Lo SS, Dawson LA, Kim EY, Mayr NA, Wang
JZ, Huang Z and Cardenes HR: Stereotactic body radiation therapy
for hepatocellular carcinoma. Discov Med. 9:404–410.
2010.PubMed/NCBI
|
|
4
|
Petrelli A, Perra A, Cora D, Sulas P,
Menegon S, Manca C, Migliore C, Kowalik MA, Ledda-Columbano GM,
Giordano S, et al: MicroRNA/gene profiling unveils early molecular
changes and nuclear factor erythroid related factor 2 (NRF2)
activation in a rat model recapitulating human hepatocellular
carcinoma (HCC). Hepatology. 59:228–241. 2014. View Article : Google Scholar
|
|
5
|
Valadi H, Ekström K, Bossios A, Sjöstrand
M, Lee JJ and Lötvall JO: Exosome-mediated transfer of mRNAs and
microRNAs is a novel mechanism of genetic exchange between cells.
Nat Cell Biol. 9:654–659. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li Y and Kowdley KV: MicroRNAs in common
human diseases. Genomics Proteomics Bioinformatics. 10:246–253.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bala S, Petrasek J, Mundkur S, Catalano D,
Levin I, Ward J, Alao H, Kodys K and Szabo G: Circulating microRNAs
in exosomes indicate hepatocyte injury and inflammation in
alcoholic, drug-induced, and inflammatory liver diseases.
Hepatology. 56:1946–1957. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Waidmann O, Bihrer V, Pleli T, Farnik H,
Berger A, Zeuzem S, Kronenberger B and Piiper A: Serum microRNA-122
levels in different groups of patients with chronic hepatitis B
virus infection. J Viral Hepat. 19:e58–e65. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Waidmann O, Köberle V, Brunner F, Zeuzem
S, Piiper A and Kronenberger B: Serum microRNA-122 predicts
survival in patients with liver cirrhosis. PLoS One. 7:e456522012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang J, Li J, Shen J, Wang C, Yang L and
Zhang X: MicroRNA-182 downregulates metastasis suppressor 1 and
contributes to metastasis of hepatocellular carcinoma. BMC Cancer.
12:2272012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lamba V, Ghodke-Puranik Y, Guan W and
Lamba JK: Identification of suitable reference genes for hepatic
microRNA quantitation. BMC Res Notes. 7:1292014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kutay H, Bai S, Datta J, Motiwala T,
Pogribny I, Frankel W, Jacob ST and Ghoshal K: Downregulation of
miR-122 in the rodent and human hepatocellular carcinomas. J Cell
Biochem. 99:671–678. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ladeiro Y, Couchy G, Balabaud C,
Bioulac-Sage P, Pelletier L, Rebouissou S and Zucman-Rossi J:
MicroRNA profiling in hepatocellular tumors is associated with
clinical features and oncogene/tumor suppressor gene mutations.
Hepatology. 47:1955–1963. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li LM, Hu ZB, Zhou ZX, Chen X, Liu FY,
Zhang JF, Shen HB, Zhang CY and Zen K: Serum microRNA profiles
serve as novel biomarkers for HBV infection and diagnosis of
HBV-positive hepatocarcinoma. Cancer Res. 70:9798–9807. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Meng F, Henson R, Wehbe-Janek H, Ghoshal
K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the
PTEN tumor suppressor gene in human hepatocellular cancer.
Gastroenterology. 133:647–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pineau P, Volinia S, McJunkin K, Marchio
A, Battiston C, Terris B, Mazzaferro V, Lowe SW, Croce CM and
Dejean A: miR-221 overexpression contributes to liver
tumorigenesis. Proc Natl Acad Sci USA. 107:264–269. 2010.
View Article : Google Scholar :
|
|
17
|
Huang X and Jia Z: Construction of
HCC-targeting artificial miRNAs using natural miRNA precursors. Exp
Ther Med. 6:209–215. 2013.PubMed/NCBI
|
|
18
|
Xu J, Wu C, Che X, Wang L, Yu D, Zhang T,
Huang L, Li H, Tan W, Wang C, et al: Circulating microRNAs, miR-21,
miR-122, and miR-223, in patients with hepatocellular carcinoma or
chronic hepatitis. Mol Carcinog. 50:136–142. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou J, Yu L, Gao X, Hu J, Wang J, Dai Z,
Wang JF, Zhang Z, Lu S, Huang X, et al: Plasma microRNA panel to
diagnose hepatitis B virus-related hepatocellular carcinoma. J Clin
Oncol. 29:4781–4788. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tan Y, Ge G, Pan T, Wen D, Chen L, Yu X,
Zhou X and Gan J: A serum microRNA panel as potential biomarkers
for hepatocellular carcinoma related with hepatitis B virus. PLoS
One. 9:e1079862014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tan Y, Ge G, Pan T, Wen D and Gan J: A
pilot study of serum microRNAs panel as potential biomarkers for
diagnosis of nonalcoholic fatty liver disease. PLoS One.
9:e1051922014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Peltier HJ and Latham GJ: Normalization of
microRNA expression levels in quantitative RT-PCR assays:
Identification of suitable reference RNA targets in normal and
cancerous human solid tissues. RNA. 14:844–852. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang H, Li QY, Guo ZZ, Guan Y, Du J, Lu
YY, Hu YY, Liu P, Huang S and Su SB: Serum levels of microRNAs can
specifically predict liver injury of chronic hepatitis B. World J
Gastroenterol. 18:5188–5196. 2012.PubMed/NCBI
|
|
24
|
Li G, Cai G, Li D and Yin W: MicroRNAs and
liver disease: Viral hepatitis, liver fibrosis and hepatocellular
carcinoma. Postgrad Med J. 90:106–112. 2014. View Article : Google Scholar
|
|
25
|
Li ZJ, Ou-Yang PH and Han XP: Profibrotic
effect of miR-33a with Akt activation in hepatic stellate cells.
Cell Signal. 26:141–148. 2014. View Article : Google Scholar
|
|
26
|
Marin JJ, Bujanda L and Banales JM:
MicroRNAs and cholestatic liver diseases. Curr Opin Gastroenterol.
30:303–309. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Papaconstantinou I, Karakatsanis A,
Gazouli M, Polymeneas G and Voros D: The role of microRNAs in liver
cancer. Eur J Gastroenterol Hepatol. 24:223–228. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mei Q, Li X, Meng Y, Wu Z, Guo M, Zhao Y,
Fu X and Han W: A facile and specific assay for quantifying
microRNA by an optimized RT-qPCR approach. PLoS One. 7:e468902012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Salvi A, Abeni E, Portolani N, Barlati S
and De Petro G: Human hepatocellular carcinoma cell-specific miRNAs
reveal the differential expression of miR-24 and miR-27a in
cirrhotic/non-cirrhotic HCC. Int J Oncol. 42:391–402. 2013.
|
|
30
|
Xu RH, Zheng LY, He DL, et al: Profiling
of differentially expressed microRNAs (miRNAs) during
differentiation of rat hepatic oval cells (HOCs) into
hepatocellular carcinoma (HCC) cells. Clin Transl Oncol.
17:230–237. 2015. View Article : Google Scholar
|
|
31
|
Li J, Wang Y, Yu W, Chen J and Luo J:
Expression of serum miR-221 in human hepatocellular carcinoma and
its prognostic significance. Biochem Biophys Res Commun. 406:70–73.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tomimaru Y, Eguchi H, Nagano H, Wada H,
Kobayashi S, Marubashi S, Tanemura M, Tomokuni A, Takemasa I,
Umeshita K, et al: Circulating microRNA-21 as a novel biomarker for
hepatocellular carcinoma. J Hepatol. 56:167–175. 2012. View Article : Google Scholar
|
|
33
|
Murakami Y, Yasuda T, Saigo K, Urashima T,
Toyoda H, Okanoue T and Shimotohno K: Comprehensive analysis of
microRNA expression patterns in hepatocellular carcinoma and
non-tumorous tissues. Oncogene. 25:2537–2545. 2006. View Article : Google Scholar
|
|
34
|
Jiang J, Gusev Y, Aderca I, Mettler TA,
Nagorney DM, Brackett DJ, Roberts LR and Schmittgen TD: Association
of microRNA expression in hepatocellular carcinomas with hepatitis
infection, cirrhosis, and patient survival. Clin Cancer Res.
14:419–427. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hou J, Lin L, Zhou W, Wang Z, Ding G, Dong
Q, Qin L, Wu X, Zheng Y, Yang Y, et al: Identification of miRNomes
in human liver and hepatocellular carcinoma reveals miR-199a/b-3p
as therapeutic target for hepatocellular carcinoma. Cancer Cell.
19:232–243. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Morita K, Taketomi A, Shirabe K, Umeda K,
Kayashima H, Ninomiya M, Uchiyama H, Soejima Y and Maehara Y:
Clinical significance and potential of hepatic microRNA-122
expression in hepatitis C. Liver Int. 31:474–484. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chang J, Nicolas E, Marks D, Sander C,
Lerro A, Buendia MA, Xu C, Mason WS, Moloshok T, Bort R, et al:
miR-122, a mammalian liver-specific microRNA, is processed from hcr
mRNA and may downregulate the high affinity cationic amino acid
transporter CAT-1. RNA Biol. 1:106–113. 2004. View Article : Google Scholar
|
|
38
|
Datta J, Kutay H, Nasser MW, Nuovo GJ,
Wang B, Majumder S, Liu CG, Volinia S, Croce CM, Schmittgen TD, et
al: Methylation mediated silencing of microRNA-1 gene and its role
in hepatocellular carcinogenesis. Cancer Res. 68:5049–5058. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hsu SH, Wang B, Kota J, Yu J, Costinean S,
Kutay H, Yu L, Bai S, La Perle K, Chivukula RR, et al: Essential
metabolic, anti-inflammatory, and anti-tumorigenic functions of
miR-122 in liver. J Clin Invest. 122:2871–2883. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tsai WC, Hsu SD, Hsu CS, Lai TC, Chen SJ,
Shen R, Huang Y, Chen HC, Lee CH, Tsai TF, et al: MicroRNA-122
plays a critical role in liver homeostasis and
hepatocarcinogenesis. J Clin Invest. 122:2884–2897. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kota J, Chivukula RR, O’Donnell KA,
Wentzel EA, Montgomery CL, Hwang HW, Chang TC, Vivekanandan P,
Torbenson M, Clark KR, et al: Therapeutic microRNA delivery
suppresses tumorigenesis in a murine liver cancer model. Cell.
137:1005–1017. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ji J, Shi J, Budhu A, Yu Z, Forgues M,
Roessler S, Ambs S, Chen Y, Meltzer PS, Croce CM, et al: MicroRNA
expression, survival, and response to interferon in liver cancer. N
Engl J Med. 361:1437–1447. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Qu KZ, Zhang K, Li H, Afdhal NH and
Albitar M: Circulating microRNAs as biomarkers for hepatocellular
carcinoma. J Clin Gastroenterol. 45:355–360. 2011. View Article : Google Scholar : PubMed/NCBI
|
